Kaipharm Co. Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Kaipharm Co. Ltd. - overview
Established
2018
Location
Seoul, -, South Korea
Primary Industry
Biotechnology
About
Based in Seoul, South Korea, and founded in 2018 by CEO Wankyu Kim, Kaipharm Co. Ltd. , a. k.
a. Kaipharm is an AI (artificial intelligence)-driven drug discovery company that builds a database of compound structures, drug-disease relationships, drug-target relationships, drug-induced transcriptome, and data mining technologies for developing artificial intelligence (AI) algorithms and providing complex solutions. In February 2020, Kaipharm Co. Ltd.
raised USD 4. 2 million in a Series A funding. The company provides a drug-induced transcriptome platform that offers information on drug mode-of-action (MoA), reflecting genome-wide perturbation on gene expression by drug treatment for targets and unknown off-targets. Kaipharm also offers KMAP, an integrated platform for analyzing drug-induced transcriptome data that enables MoA analysis and identification of novel indications for a given drug.
In addition, the firm performs large-scale mining for drug screening and bioassay datasets. The company has developed multiple virtual screening technologies, such as BEAR (bioactive compound enrichment by assay repositioning) registered in US and Korea, and BACoN registered in Korea patents for drug virtual screening services.
Current Investors
Innopolis Partners, KB Investment, Kolon Investment
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.kaipharm.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.